Research Article
Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients
Table 1
Baseline anthropometrical and biochemical comparison between NAFLD and controls (chronic hepatitis B (CHB)).
| Parameters | NAFLD () | CHB () | value |
| Age | | | 0.74 | BMI | | | 0.10 | Waist circumference | | | 0.01 | Waist/hip ratio | | | 0.27 | Waist/height ratio | | | 0.23 | SBP | | | 0.65 | DBP | | | 0.77 | Total bilirubin | | | 0.51 | AST | | | 0.08 | ALT | | | 0.07 | Alkaline phosphatase | | | 0.005 | Total protein | | | 0.45 | Albumin | | | 0.73 | Globulin | | | 0.42 | GGT | | | 0.17 | Insulin | | | 0.02 | HOMA IR | | | 0.01 | FBS | | | 0.32 | 2hour PPBS | | | 0.05 | Triglycerides | | | 0.70 | Total cholesterol (TC) | | | 0.08 | HDL | | | 0.37 | LDL | | | 0.04 | VLDL | | | 0.41 | LDL/HDL | | | 0.99 | TC/HDL | | | 0.29 |
|
|